Dendritic cells in viral infections

Handbook of Experimental Pharmacology

Volumn 188, Issue , 2009, Pages 51-77

  Belz, Gabrielle ^a   Mount, Adele ^b   Masson, Frederick ^b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; DENDRITIC CELL; EFFECTOR CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPH NODE; LYMPHOID ORGAN; LYMPHOID TISSUE; MEMORY CELL; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; ANIMAL; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY; VIRUS DISEASES;

EID: 60549118045     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-71029-5_3     Document Type: Review

References (162)

1. Ackerman AL, Cresswell P (2004) Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 5:678-684
2. Ahn K et al (1996) Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93:10990-10995
3. Akashi K et al (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-197
4. Albert ML et al (1998a) Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188:1359-1368
5. Albert ML et al (1998b) Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLs. Nature 392:86-89
6. + dendritic cells but not by Langerhans cells. Science 301:1925-1928
7. Allan RS et al (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153-162
8. Andoniou CE et al (2005) Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 6:1011-1019
9. Andrews DM et al (2005) Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 42:547-555
10. Andrews DMet al (2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4:175-181
11. Arase H et al (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326
12. Asselin-Paturel C et al (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2:1144-1150
13. Banchereau J et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811
14. Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
15. Bancroft GJ et al (1981) Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 126: 988-994
16. Barchet W et al (2005) Plasmacytoid dendritic cells-virus experts of innate immunity. Semin Immunol 17:253-261
17. Barr DP et al (2007) A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur J Immunol 37:1334-1342
18. Basta S, Alatery A (2007) The cross-priming pathway: a portrait of an intricate immune system. Scand J Immunol 65:311-319
19. Belkaid Y and Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6:353-360
20. Bell D et al (1999) Dendritic cells. Advances in Immunology 72:255-324
21. Belz GT et al (2002) Cross-presentation of antigens by dendritic cells. Crit Rev Immunol 22:439-448
22. + dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J Immunol 175:196-200
23. + dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol 172:1996-2000
24. Belz GT et al (2004b) Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci USA 101:8670-8675
25. + T cell responses in pathogen infections through antigen presentation. Adv Exp Med Biol 590:31-42
26. + T cells in response to viral infections of the lung and skin. Eur J Immunol 36:327-335
27. Bennett NJ et al (2005) Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol 3:e120
28. Bevan MJ (1976) Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143:1283-1288
29. + T cells. J Clin Investig 94:797-807
30. Biron CA (1999) Initial and innate responses to viral infections - pattern setting in immunity or disease. Curr Opin Microbiol 2:374-381
31. Boname JM et al (2004) Viral degradation of the MHC class I peptide loading complex. Immunity 20:305-317
32. Borrow P et al (1995) Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 69:1059-1070
33. Bowie A et al (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci USA 97:10162-10167
34. Bronte V, Zanovello P (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5:641-654
35. Bubeck A et al (2002) The glycoprotein gp48 of murine cytomegalovirusL proteasome-dependent cytosolic dislocation and degradation. J Biol Chem 277:2216-2224
36. Carrasco YR, Batista FD (2007) B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27:160-171
37. Caux C et al (1994) B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 180:1841-1847
38. Cella M et al (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919-923
39. Coscoy L, Ganem D (2001) A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Investig 107:1599-1606
40. D'Amico A, Wu L (2003) The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med 198:293-303
41. Degli-Esposti MA, Smyth MJ (2005) Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5:112-124
42. - dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192:1685-1696
43. Ferguson TA, Griffith TS (2006) A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev 213:228-238
44. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med 198:201-209
45. FleetonMNet al (2004) Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J Exp Med 200:235-245
46. Fruh K et al (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418
47. Gazit R et al (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7:517-523
48. Geissmann F et al (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82
49. Gerosa F et al (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327-333
50. Ginhoux F et al (2006) Langerhans cells arise from monocytes in vivo. Nat Immunol 7:265-273
51. Granucci F et al (2004) A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 200:287-295
52. Guermonprez P et al (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667
53. Harshyne LA et al (2001) Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 166:3717-3723
54. Hawiger D et al (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769-779
55. + T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24:643-656
56. Heath WR et al (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199:9-26
57. Henri S et al (2001) The dendritic cell populations of mouse lymph nodes. J Immunol 167:741-748
58. Hill A et al (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415
59. Hoebe K et al (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748
60. Inaba K et al (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702
61. Inaba K et al (2000) The formation of immunogenic major histocompatibility complex class IIpeptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 191:927-936
62. + dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J Immunol 169: 2247-2252
63. Ishido S et al (2000) Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300-5309
64. Itano AA et al (2003) Distinct dendritic cell populations sequentially present antigen to CD4 T cellsand stimulate different aspects of cell-mediated immunity. Immunity 19:47-57
65. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195:1289-1302
66. + T cells by exogenous cell-associated antigens. Immunity 17:211-220
67. Junt T et al (2007) Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450:110-114
68. + dendritic cells in vivo. J Exp Med 198:305-313
69. Keir ME et al (2007) PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 19:309-314
70. Kleijnen MF et al (1997) A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. Embo J 16:685-694
71. Kondo M et al (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-672
72. Kotenko SV et al (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL- 10). Proc Natl Acad Sci USA 97:1695-1700
73. Krmpotic A et al (2005) NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201:211-220
74. Krmpotic A et al (1999) The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med 190:1285-1296
75. Krutzik SR et al (2005) TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 11:653-660
76. Kupresanin F et al (2007) Dendritic cells present lytic antigens and maintain function throughout persistent γ-herpesvirus infection. J Immunol 179:7506-7513
77. Kushnir N et al (1998) Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependence, and regulation by cross-linking surface molecules. J Immunol 160:1774-1781
78. Legge KL, Braciale TJ (2003) Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18:265-277
79. + dendritic cells is sufficient for control of Leishmania major. J Exp Med 199:725-730
80. Leon B et al (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26:519-531
81. Li K et al (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102:2992-2997
82. Lilley BN, Ploegh HL (2005) Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 207:126-144
83. Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275-306
84. Lockridge KM et al (2000) Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272-280
85. Lodoen M et al (2003) NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197:1245-1253
86. Loo YM et al (2006) Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci USA 103:6001-6006
87. Loureiro J, Ploegh HL (2006) Antigen presentation and the ubiquitin-proteasome system in hostpathogen interactions. Adv Immunol 92:225-305
88. Macatonia SE et al (1987) Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 166:1654-1667
89. Mandelboim O et al (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055-1060
90. Manickasingham S, Reise Sousa C (2000) Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J Immunol 165:5027-5034
91. Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255-258
92. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774
93. Mellor AL, Munn DH (2008) Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8(1):74-80
94. Menard C et al (2003) Role of murine cytomegalovirus US22 gene family members in replicationin macrophages. J Virol 77:5557-5570
95. Merad M (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135-1141
96. Meylan E et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172
97. Mintern JD et al (2006) Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol 177:8422-8431
98. + T cells after viral stimulation. PLoS ONE 3:: e1691
99. Munks MW et al (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178: 7235-7241
100. Naik SH et al (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7:663-671
101. + T cells by infected dendritic cells in vivo. Nat Immunol 3:265-271
102. + T cells in vivo. J Immunol 166:4355-4362
103. + dendritic cells only after microbial stimulus.J Exp Med 196:1307-1319
104. Odermatt B et al (1991) Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci USA 88:8252-8256
105. Okazaki T, Honjo T (2006) The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 27:195-201
106. Orange JS, Biron CA (1996) Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 156:4746-4756
107. Pape KA et al (2007) The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26:491-502
108. Parry CM et al (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191:573-578
109. Phan TG et al (2007) Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 8:992-1000
110. Pierre P et al (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-792
111. + dendritic cells. J Immunol 166:5327-5330
112. Probst HC et al (2002) Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses. J Immunol 168:5387-5391
113. Pulendran B et al (1997) Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand- treated mice. J Immunol 159:2222-2231
114. Qi H et al (2006) Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312:1672-1676
115. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151-177
116. Reise Sousa C (2006) Dendritic cells in a mature age. Nat Rev Immunol 6:476-483 Romani N et al (1989) Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med169:1169-1178
117. Roy DJ et al (2000) Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch Virol 145:2411-2420
118. Salomon B et al. (1998) Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol 160:708-717
119. Schlender J et al (2005) Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79:5507-5515
120. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 103:10729-10734
121. Schuler G, Steinman RM (1985) Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161:526-546
122. + dendritic cells is attributable to their ability to internalize dead cells. Immunology 107:183-189
123. Serbina NV et al (2003a) Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 19:891-901
124. Serbina NV et al (2003b) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70
125. Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116-126 Shortman K, Naik SH (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7:19-30
126. Sigal LJ et al (1999) Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen [see comments]. Nature 398:77-80
127. Sixt M et al (2005) The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22:19-29
128. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J Immunol 170:4437-4440
129. Smith CM et al (2007) Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells. PLoS ONE 2:e1048
130. Smith HR et al (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99:8826-8831
131. Stack J et al (2005) Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201:1007-1018
132. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296
133. Steinman RM, Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1142-1162
134. + T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol 29:1059-1067
135. Stevenson PG et al (2000) Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci USA 97:8455-8460
136. +T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3:733-740
137. Stoitzner P et al (2003) Visualization and characterization of migratory Langerhans cells in murineskin and lymph nodes by antibodies against Langerin/CD207. J Investig Dermatol 120:266-274
138. + T cell responses. J Exp Med 198:889-901
139. Tabeta K et al (2004) Toll-like receptors 9 and 3 as essential components of innate immune defenseagainst mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101:3516-3521
140. Tabeta K et al (2006) The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signalingvia Toll-like receptors 3, 7 and 9. Nat Immunol 7:156-164
141. Tang Q et al (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7:83-92
142. Tang Q, Bluestone JA (2006) Plasmacytoid DCs and T(reg) cells: casual acquaintance or monogamous relationship? Nat Immunol 7:551-553
143. Taylor PR et al (2005) Macrophage receptors and immune recognition. Annu Rev Immunol23:901-944
144. Thomas S et al (2007) Antigen presentation by nonhemopoietic cells amplifies clonal expansion of effector CD8 T cells in a pathogen-specific manner. J Immunol 178:5802-5811
145. Turley SJ et al (2000) Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522-527
146. Valchanova RS et al (2006) Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 80:10181-10190
147. Vermaelen KY et al (2001) Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 193:51-60
148. Vremec D et al (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus andspleen. J Immunol 164:2978-2986
149. Vremec D, Shortman K (1997) Dendritic cell subtypes in mouse lymphoid organs: crosscorrelation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 159:565-573
150. Vremec D et al (1992) The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med 176:47-58
151. West MA et al. (2004) Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305:1153-1157
152. Wilson NS et al (2003) Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187-2194
153. Wilson NS, Villadangos JA (2004) Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm. Immunol Cell Biol 82:91-98
154. Wilson NS et al (2008) Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol Cell Biol 86: 200-205
155. Winzler C et al (1997) Maturation stages of mouse dendritic cells in growth factor-dependent longterm cultures. J Exp Med 185:317-328
156. Witmer-Pack MD et al (1993) Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci 104:1021-1029
157. Yewdell JW, Haeryfar SM (2005) Understanding presentation of viral antigens to CD8 + T cells in vivo: the key to rational vaccine design. Annu Rev Immunol 23:651-682
158. Yewdell JW, Hill AB (2002) Viral interference with antigen presentation. Nat Immunol 3:1019-1025
159. + T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol 73:1-77
160. Zammit DJ et al (2005) Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22:561-570
161. Zhao X et al (2003) Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197:153-162
162. Zuniga EI et al (2004) Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 5:1227-1234